← Eichor
Study identifier: NCT06881641 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study on Bedside Formate Assay as a Diagnostic Tool in Methanol Poisoning

Condition: Metabolic Acidosis  ·  Sponsor: University of Edinburgh

PhaseN/A
Planned participants6120
Who can joinAll sexes, 16 Years to no upper limit
Healthy volunteersNo

About this study

Methanol poisoning is a serious issue, particularly in low- and middle-income countries (LMICs), where outbreaks can devastate communities. Diagnosing methanol poisoning is challenging because its symptoms mimic many other conditions, and traditional diagnostic methods require expensive lab equipment. Unfortunately, this often means doctors do not even consider methanol poisoning as a diagnosis. Methanol itself isn't highly toxic, but when the body breaks it down into formate, it becomes dangerous, leading to brain swelling and even death. To address this, a study team has developed a new method to diagnose methanol poisoning using a single drop of blood with a device that can be used at the bedside, eliminating the need for any lab equipment. This point-of-care (POC) test measures formate, which is only present in cases of methanol poisoning. The project consists of two sequential studies. The first study aims to compare the effectiveness of the POC formate test against standard lab tests, which can take several hours. The findings from this study will inform the second study. The second study is a feasibility cluster randomized controlled trial. In this trial, entire hospitals, rather than individual patients, are randomly assigned different approaches, similar to tossing a coin. The goal is to determine whether this trial design can be used in larger-scale research to evaluate clinical outcomes. Specifically, it will examine whether the POC formate test can accelerate a…

This description comes directly from the study's public registry record.

Talk to the study team

Prof Michael Eddleston, BA PhDScD FRCPEdin FEAPCCT  ·  0131 242 6776  ·  M.Eddleston@ed.ac.uk

Michael Eddleston

Always discuss trial participation with your own doctor first.

Locations (6)

SZMCHBogra, Bogura, BangladeshRecruiting
Rahshahi medical college hospitalRajshahi, Rajshahi Division, BangladeshRecruiting
Chittagong Medical College HospitalChittagong, BangladeshRecruiting
Dhaka Medical College HospitalDhaka, BangladeshRecruiting
Mag Osmania Medical College Hospital SylhetSylhet, BangladeshRecruiting
PGIEMRChandigarh, IndiaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06881641